186 related articles for article (PubMed ID: 21225022)
1. Temozolomide: Expanding its role in brain cancer.
Mrugala MM; Adair J; Kiem HP
Drugs Today (Barc); 2010 Nov; 46(11):833-46. PubMed ID: 21225022
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide in malignant gliomas: current use and future targets.
Villano JL; Seery TE; Bressler LR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
Friedman HS
Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
5. Current and future developments in the use of temozolomide for the treatment of brain tumours.
Stupp R; Gander M; Leyvraz S; Newlands E
Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
[TBL] [Abstract][Full Text] [Related]
6. Future directions for temozolomide therapy.
Yung WK
Semin Oncol; 2001 Aug; 28(4 Suppl 13):43-6. PubMed ID: 11550138
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide: realizing the promise and potential.
Nagasubramanian R; Dolan ME
Curr Opin Oncol; 2003 Nov; 15(6):412-8. PubMed ID: 14624222
[TBL] [Abstract][Full Text] [Related]
8. New approaches for temozolomide therapy: use in newly diagnosed glioma.
Stupp R; Newlands E
Semin Oncol; 2001 Aug; 28(4 Suppl 13):19-23. PubMed ID: 11550135
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide: a novel oral alkylating agent.
Danson SJ; Middleton MR
Expert Rev Anticancer Ther; 2001 Jun; 1(1):13-9. PubMed ID: 12113120
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review.
Dinnes J; Cave C; Huang S; Major K; Milne R
Health Technol Assess; 2001; 5(13):1-73. PubMed ID: 11359682
[No Abstract] [Full Text] [Related]
11. Temozolomide: a milestone in neuro-oncology and beyond?
Mutter N; Stupp R
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1187-204. PubMed ID: 16925485
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide in malignant gliomas.
Yung WK
Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
[TBL] [Abstract][Full Text] [Related]
13. Promises and controversies in the management of low-grade glioma.
Stupp R; Baumert BG
Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
[No Abstract] [Full Text] [Related]
14. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide in patients with high grade gliomas.
Brandes AA; Pasetto LM; Vastola F; Monfardini S
Oncology; 2000 Sep; 59(3):181-6. PubMed ID: 11053983
[TBL] [Abstract][Full Text] [Related]
16. First-line therapy with temozolomide induces regression of primary CNS lymphoma.
Herrlinger U; Küker W; Platten M; Dichgans J; Weller M
Neurology; 2002 May; 58(10):1573-4. PubMed ID: 12034807
[No Abstract] [Full Text] [Related]
17. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
[TBL] [Abstract][Full Text] [Related]
18. [Problems of chemotherapy for glioma].
Hirose Y
Gan To Kagaku Ryoho; 2011 Jun; 38(6):923-6. PubMed ID: 21751527
[No Abstract] [Full Text] [Related]
19. [Regulation of MGMT and application for the therapy to attenuate the chemoresistance].
Kohsaka S; Kanno H; Tanaka S
Nihon Rinsho; 2012 Nov; 70 Suppl 8():346-52. PubMed ID: 23513864
[No Abstract] [Full Text] [Related]
20. Temozolomide (Temodal) for treatment of primary brain tumours.
MacConnachie AM
Intensive Crit Care Nurs; 2000 Feb; 16(1):59-60. PubMed ID: 10790718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
